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Background: The corpus callosum is the largest white matter tract in the human brain, 
involved in inter-hemispheric transfer and integration of lateralised visual, sensory-motor, 
language, and cognitive information. Microstructural alterations are implicated in ageing as 
well as various neurological conditions.  
New Method: Cross-sectional diffusion-weighted images of 107 healthy adults were used to 
create a linear regression model of the ageing corpus callosum and its sub-regions to evaluate 
the impact of analysis by sub-region, and to test for deviations from healthy ageing 
parameters in 28 subjects with mild cognitive impairment (MCI). Alterations in diffusion 
properties including fractional anisotropy, mean, radial and axial diffusivities were 
investigated as a function of age. 
Results: Changes in DTI parameters showed age-dependent regional differences, likely arising 
from axonal diameter variation across cross-sectional regions of interest in the corpus 
callosum. Patterns suggestive of degeneration with healthy ageing were observed in all 
regions. Diffusion parameters in sub-regions projecting to pre-motor, primary, and 
supplementary motor areas of the brain differed for MCI versus healthy controls, and MCI 
subjects were more likely than healthy controls to experience a reduction in motor skills. 
Comparison with Existing Methods: Statistical analyses of the corpus callosum by five 
manually-defined sub-regions, instead of a single manually-defined region of interest, 
revealed region-specific changes in microstructure in healthy ageing and MCI, and accounted 
for clinically-evaluated differences in motor skills between cohorts.  
Conclusion: This method will support future studies of corpus callosum, enabling 
identification and measurement of white matter changes that are undetectable with the 




The topology of the human brain is constantly changing from birth, plateauing in adulthood 
and degenerating in later life. Both grey matter and white matter tissues in the brain are 
susceptible to ageing, with observations in post-mortem studies of healthy human brains of 
more severe age-related changes in white matter than in grey matter (Marner et al., 2003; 
Piguet et al., 2009). The corpus callosum is the largest white matter tract in the human brain, 
with more than 300 million fibres interconnecting the two cerebral hemispheres. Recent 
technological advances have found fibres of the corpus callosum projecting into prefrontal, 
pre-motor, supplementary and primary motor, and sensory areas of the brain (Hofer and 
Frahm, 2006), and involved in inter-hemispheric transfer and integration of lateralised visual, 
sensory-motor, language and cognitive information (van der Knaap and van der Ham, 2011). 
Corpus callosum anatomy has been divided into sub-regions based on geometry (Clarke and 
Zaidel, 1994; Witelson, 1989), connectivity (Hofer and Frahm, 2006), and statistically derived 
cohesiveness (Denenberg et al., 1991; Peters et al., 2002). Studies on effects of age, sex and 
handedness in the healthy brain have reported differences in these properties in the corpus 
callosum by sub-region (Peters et al., 2002; Prendergast et al., 2015; Reuter-Lorenz and 
Stanczak, 2000; Sullivan et al., 2001b; Witelson, 1989). 
 
Post-mortem studies have linked altered properties of the corpus callosum to normal ageing 
(Hou and Pakkenberg, 2012) as well as neurological disorders including schizophrenia 
(Woodruff et al., 1995), multiple sclerosis (Evangelou et al., 2000), Huntington's disease and 
progressive supranuclear palsy (Mann et al., 1993). Recent magnetic resonance imaging (MRI) 
studies have strengthened these conclusions with evidence of atrophy (Goldman et al., 2017; 
Granberg et al., 2015; Lee et al., 2016; Wang et al., 2015a), morphological changes (Ardekani 
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et al., 2014; Pardoe et al., 2015; Wolff et al., 2015), and demyelination in the human corpus 
callosum (Decker et al., 2018; Køster et al., 2018) and mouse models (Xiu et al., 2015). 
Diffusion tensor magnetic resonance imaging (DT-MRI or DTI) has also been applied to study 
the corpus callosum. DTI is an advanced technique that is used to image the diffusion 
properties of water molecules in tissue, providing a means to interpret the presence or 
absence of barriers to this diffusion (Le Bihan et al., 2001). DTI has been previously used to 
study the microstructural properties of the corpus callosum in healthy ageing and various 
neurological disorders (Hasan et al., 2005; Shahab et al., 2018; Sullivan and Pfefferbaum, 
2003).  
 
The corpus callosum is reportedly the white matter structure most affected by age (Sala et 
al., 2012), with some studies also revealing differences in the extent to which its sub-regions 
are affected (Ota et al., 2006). These variations between the sub-regions have been suggested 
as indicative of the differing effects of age in the corresponding parts of the brain they project 
to (Lebel et al., 2010; Ota et al., 2006). However, there are conflicting study results in the 
literature with some indicating a larger effect of age in the anterior corpus callosum than in 
the posterior (Hasan et al., 2005; Lebel et al., 2010; Ota et al., 2006; Sullivan et al., 2001a, 
2001b), and a few suggesting the opposite (Bennett et al., 2017). MRI and DTI studies of the 
corpus callosum have also been carried out for various neurological disorders including mild 
cognitive impairment (MCI) and Alzheimer's disease (AD) (Ardekani et al., 2014; Lee et al., 
2016; Wang et al., 2015b). Results of these studies indicate degeneration of the corpus 




The corpus callosum incorporates a heterogeneous bundle of fibres connecting the 
hemispheres of the brain. Different segments of this fibre bundle have been observed to be 
of different sizes or diameters, likely depending on the region of the brain they project to 
(Aboitiz et al., 1992). This may have an impact on the quantitative parameters measured in 
vivo, particularly in DTI. In previous DTI investigations of the corpus callosum in healthy ageing 
and disease, it has been treated as a single region of interest (ROI), and/or by sub-region (Ma 
et al., 2009, Bennett et al., 2017, Feng et al., 2018, Ota et al., 2006, Lebel et al., 2010). While 
a single ROI approach is easier to implement, the heterogeneity of the corpus callosum may 
be better represented through a region-wise analysis. This, in turn, may be influenced by the 
choice of scheme used to define the sub-regions.  Here, we investigated DTI properties of the 
corpus callosum as a function of age and tested for cohort differences between ageing healthy 
controls (HC) and individuals with MCI, examining how this is influenced by segmenting the 
corpus callosum as a single ROI and by sub-region. Strategies for segmentation of the corpus 
callosum were explored. The data available to this study were acquired in the axial plane, but 
the corpus callosum is better delineated in the sagittal plane, so at the outset comparisons 
were made between atlas-based and manual delineation of the corpus callosum to determine 
the most appropriate strategy for this study. Having selected a manual delineation approach, 
the Hofer and Frahm scheme (segmenting in the sagittal plane to create pre-defined 
fractions), was used to divide the corpus callosum into five sub-regions for analysis (Hofer and 
Frahm, 2006). 
 
2. Materials and Methods 
Data used in this study were obtained from the Alzheimer's Disease Neuroimaging Initiative 
(ADNI) database (http://adni.loni.usc.edu). ADNI was launched in 2003 as a public-private 
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partnership, led by Principal Investigator Michael W. Weiner, MD. The primary goal of ADNI 
has been to test whether serial MRI, positron emission tomography, other biological markers, 
and clinical and neuropsychological assessments can be combined to measure the 
progression of MCI and early AD.  ADNI consists of a series of multi-site data acquisition 
studies, with ADNI-1, ADNI-2, and ADNI-GO completed to date; ADNI-3 is ongoing. This study 
used data from ADNI-3, in order to utilize DTI data acquired at higher spatial resolution than 
in the previous ADNI studies. The primary inclusion criterion was that the image data were 
acquired with a set of fully-matched scan parameters. Prior studies confirm the importance 
of ensuring a consistent set of acquisition scan parameters to avoid introducing experimental 
uncertainty into the quantitative results, where their selection reportedly affects diffusion 
tensor estimation in DTI (Landman et al., 2007; Zavaliangos-Petropulu et al., 2019, Zhu et al., 
2009).  Application of this criterion to the full cohort in ADNI-3 produced a choice of three 
study cohorts (Siemens, GE, or Philips), and the largest of these at the time of analysis 
(Siemens) was selected, providing 140 subjects (107 HC, 28 MCI, 5 AD).  All these HC and MCI 
subjects were included in the present study.  Although the sample sizes for HC and MCI 
differed, this was carefully considered and accommodated for in the choice of statistical 
methods for comparison between the groups.  The 5 AD cases were excluded because power 
calculations to determine study group size, based on prior-published ADNI-2 data, indicated 
that the AD group was too small to include for comparison with the HC and MCI.   
 
The scan sequence details of images included in this study are: field strength = 3 T, echo time 
(TE) = 56 ms, repetition time (TR) = 7200 ms, b = 0, 1000 s/mm2, number of diffusion weighted 
images = 48, number of non-diffusion weighted images = 7, voxel size = 2 mm x 2 mm x 2 mm 
and approximate scan time = 7 mins 30 s.  
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The ADNI-3 subject images selected for use in this study were collected at the baseline visit 
for each participant. Ideally, longitudinal data from individuals would be used to analyse 
changes in DTI parameters as a function of age. In practice, a preliminary analysis (using the 
lower-spatial-resolution longitudinal data sets from ADNI-2 (Supplementary Figure S1) 
confirmed an insufficient number of participants in the ADNI-3 study cohort to support a 
longitudinal analysis. Instead, a cross-sectional analysis of the data from ADNI-3 was 
performed; this had the advantage of enabling inclusion of all HC and MCI subjects imaged 
using Siemens scanners during ADNI-3. 
 
Gender has been reported to be a significant risk factor for MCI and AD, with the longitudinal 
rate of cognitive decline in MCI observed to be greater in women than in men (Laws et al., 
2018, Lin et al., 2015). Gender-dependence of the patterns of change in DTI parameters of 
the white matter have also been observed (Kanaan et al., 2012); however, this finding is 
contradicted by others where no gender differences were observed (Inano et al., 2011). This 
apparent difference may be accounted for by factors other than gender dominating the white 
matter changes (de Schotten et al., 2011). For this reason, differences in DTI parameters as a 
function of gender were specifically tested for in the ADNI-3 cohorts studied here.   
 
To understand if gender influenced DTI parameters with ageing, HCsub (74 age- and gender-
matched healthy subjects (37 F; 37 M)) was created as a subset of the main HC study group. 
Subject demographics are summarised in Table 1. The rationale for creating HCsub was to test, 
using multiple regression, whether the DTI parameters were influenced by gender, and 
thereby to determine whether the main cohort HC or the subset HCsub was most appropriate 




Table 1: Age and gender distribution of subjects in the main healthy control (HC) and mild 
cognitive impairment (MCI) cohorts, and the gender- and age-matched HC subgroup (HCsub) 
as a subset of the HC cohort; M: male, F: female. 
Age range 
(years) 
Healthy controls Mild cognitive impairment 
Cohort M F M F 
55-60 
HC - 1 
- 2 
HCsub - - 
61-65 
HC 5 8 
1 - 
HCsub 5 5 
66-70 
HC 7 24 
2 1 
HCsub 7 7 
71-75 
HC 5 10 
4 4 
HCsub 5 5 
76-80 
HC 11 9 
3 4 
HCsub 9 9 
81-85 
HC 8 9 
1 - 
HCsub 8 8 
86-90 
HC 6 2 
1 2 
HCsub 2 2 
90-96 
HC 1 1 
1 2 
HCsub 1 1 
Total 
HC 43 64 
13 15 HCsub 37 37 
 
 
DTI scans were processed in the subject space using FSL (FMRIB Software Library, University 
of Oxford) which is a comprehensive library of tools for brain imaging data analysis (Smith et 
al., 2004). Eddy-current-induced artefacts in the scans were corrected using the 
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‘eddy_correct’ command (Jenkinson et al., 2002). The skull was removed, and the brain 
extracted from the artefact-corrected image using the ‘bet’ tool of FSL and visually verifying 
the output. Weighted fitting of the diffusion tensor on the brain was achieved using the ‘dtifit’ 
command (Jenkinson et al., 2012) and four scalar maps – fractional anisotropy (FA), mean 
diffusivity (MD), radial diffusivity (RD) and axial diffusivity (AxD) – were computed from the 
Eigen values of the tensor. 
 
2.1 Selection of corpus callosum segmentation strategy 
The ADNI DTI data were acquired in the axial plane, so ROI delineation to segment the corpus 
callosum would ideally be performed in the same plane to obtain the most accurate 
measurements.  However, the corpus callosum is not easily visualized in the axial plane, and 
in previous studies it has been segmented in the sagittal plane (Ardekani et al., 2014, Ota et 
al., 2006, Westerhausen et al., 2004).  To address this constraint, we tested several strategies 
to segment the corpus callosum, comparing the results for atlas-based and manual 
segmentation in the sagittal plane with the data obtained from the axial acquisition plane 
(considered ground truth).  A small group of ten subjects was sampled from the cohort for 
this purpose, to enable comparisons between strategies at an individual level. The result from 




Figure 1: (a) Segmentation in the axial acquisition plane: circular ROIs (see inset) placed in the 
corpus callosum in the axial plane to sample median FA values to be used as ground truth; (b) 
Strategy using atlas-based mask of corpus callosum (ICBM-DTI-81 atlas) to estimate mean and 
median of pixel-wise values; (c) Strategy using manual segmentation of the corpus callosum 
on FA image reconstructed in the sagittal plane to estimate mean and median of pixel-wise 
values; (d) Extended manual segmentation of the corpus callosum in the sagittal plane into 
five pre-determined regions based on the Hofer and Frahm scheme (schematic adapted with 
permission from Hofer and Frahm (2006)). 
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Step 1: Measurement in the axial (acquisition) plane using circular ROIs on axial FA 
image: The corpus callosum was identified on axial FA maps using anatomical 
landmarks such as the ventricles. Segmenting the whole structure in the axial plane 
was not attempted, because poor boundary definition had strong potential to increase 
experimental uncertainty in the results. Instead, using the method illustrated in prior 
studies (Bartzokis et al. 2010, Li et al., 2009), FA values were sampled with circular 
ROIs of varying radii (to avoid partial volume effects), placed throughout all axial slices 
where the corpus callosum was clearly identifiable (Figure 1a, inset). Although 
previous studies have used the mean value from these ROIs, the heterogeneous 
distribution does not necessarily follow a normal distribution. Although mean and 
median values were very similar, checks on the individual distributions for the 10 
subjects sampled for this step supported our use of the median to accommodate non-
normal distributions of pixel FA values. 
 
Step 2: Measurement using atlas-based delineation of ROI: The ICBM-DTI-81 atlas 
(Mori et al., 2008) provided with FSL, was used to obtain a mask of the corpus callosum 
using the labelled regions corresponding to the genu, the body and the splenium. Each 
subject’s FA map was registered to the Montreal Neurological Institute (MNI) 
coordinate system (Figure 1b), and the mean and median values of FA were measured 
in the ROI using the mask.  
 
Step 3: Measurement using manual delineation in the sagittal plane: In the manual 
segmentation approach, the FA image was first reconstructed in the sagittal plane, 
and the mid-sagittal slice of the brain was estimated using the method developed by 
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Freitas et al., 2011. Two slices each on either side of the mid-sagittal slice were 
segmented along with it to yield a volume of the corpus callosum consisting of five 
mid-sagittal slices (Figure 1c). The mean and the median of the FA values of the pixels 
in this ROI were estimated. 
 
Fractional anisotropy (FA) values measured using the strategies of manual segmentation in 
the sagittal plane, and atlas-based segmentation, were compared to determine which gave 
values in best agreement with those obtained manually from the axial plane (which, as the 
plane of data acquisition, was treated as ground truth for the purpose of these comparisons).    
 
For subsequent region-wise analysis, the corpus callosum was segmented into sub-regions in 
ImageJ, using the pre-defined fractions for the sagittal plane indicated in the Hofer and Frahm 
scheme (Hofer and Frahm, 2006) (Figure 1d).  It is noted that while the corpus callosum is a 
bundle of fibres connecting the left and right hemispheres of the brain (Figure 1a), analysis 
using segmentation performed in the sagittal plane parsed this bundle of fibres cross-
sectionally from anterior to posterior (Figure 1c), sampling its properties within a window of 
five sagittal slices. 
 
Manual segmentation was performed in ROIEditor (Region of Interest Editing Tools v. 1.8). 
Statistical tests, including linear regression and ANCOVA for the variation in FA, MD, RD, and 
AxD with age, were conducted using software package R using other relevant factors such as 
gender and disease group as covariates. For region-wise analysis, measurements from each 
sub-region were tested separately. Measured parameter values and codes written in R to 
carry out the analyses are available at http://wrap.warwick.ac.uk/138931 
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3. Results and Discussion 
3.1 Effects of gender on age-related changes not found significant in the cohort studied 
To test for the effects of gender, multiple linear regression analyses of FA, MD, RD and AxD 
were carried out on cohort HCsub. Age, gender, and the effect of their interaction were 
considered as factors. All four parameters exhibited linear trends with age in the age range 
analysed, in agreement with previously reported observations in the literature (Lebel et al., 
2010; Ota et al., 2006). A consistent difference was observed between male and female 
patterns of changes with age, in regression plots of MD, RD and AxD, although this was not 
statistically significant. Such an offset was not observed for FA. The corresponding figures and 
regression equations are given in Figure S2 and Table S1 in Supplementary Materials. Since 
analysis of the HCsub cohort did not indicate that gender was a statistically significant factor 
for DTI parameters as a function of age, subsequent analyses were conducted on the larger 
cohort HC using methods appropriate for application to differently sized study groups. 
 
3.2 Comparison of corpus callosum segmentation methods 
The results from the comparison of strategies for segmentation of the corpus callosum are 
shown in Figure 2. The primary constraint of the atlas-based ROI approach is evident in Figure 
1b, where the mask of the corpus callosum is misaligned with the target structure evident in 
the image contrast. The mean and median of the FA in this ROI (Figure 2: Atlas ROI (mean) 
and Atlas ROI (median)) were estimated and compared with the manually-segmented axial 
data (ground truth) and manually-segmented regions in the reconstructed sagittal plane. 
Atlas-based measurements resulted in a significant reduction in the estimated mean and 
median FA, likely due to partial volume effects. Potential issues with accuracy in the ICBM-




Figure 2: Measured values of FA in 10 subjects, using different segmentation schemes. 
Median of pixel-wise FA from multiple circular ROIs placed in the axial corpus callosum (Figure 
1a) are considered ground truth. Corresponding box plots for each strategy show the 
distribution of offsets from ground truth for the 10 subjects. The experimental uncertainty in 
the data that can arise in subject comparisons from differences in scan sequence parameters 
(Zhu et al., 2009) has been avoided by only using images acquired using fully matched 
parameters; experimental uncertainty from other sources such as eddy current artefacts have 
been reduced by post-processing. In regions with high FA such as the corpus callosum, the 
reported experimental uncertainty in FA has been very small (Zhu et al., 2009).  
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By contrast, as shown in Figure 2, median values from the manually segmented ROI in the 
sagittal plane were closest to ground truth for the 10 sampled subjects.  The slight offset of 
the FA values obtained manually in the sagittal plane compared to those from the axial plane 
may have arisen from i) the constrained sampling in the axial plane (reinforcing the need for 
ROI delineation in the sagittal plane), and/or from ii) interpolation errors arising from the 
sagittal reconstruction process. However, the similarity of the values, and the consistency of 
their distribution, indicated that this slight offset in the measured FA value would not affect 
the cohort-level relationships observed in subsequent regression analysis, and manual 
segmentation in the sagittal plane was subsequently used to obtain MD, RD, and AxD for the 
full cohort study.   
 
3.3 Linear regression analysis of HC reveals age-related changes that vary between sub-
regions, with evidence that axon diameters are a factor 
Plots of linear regression analysis of FA, MD, RD and AxD on cohort HC, are shown in Figure 
3. For all four diffusion parameters, age was a significant factor contributing to the changes 
observed (p < 0.001). Similar analyses were performed to investigate whether patterns of 
change with age were different in the sub-regions of corpus callosum (Figure 3e-h). (See 
Supplementary Materials for the corresponding regression equations.)  Analysis of covariance 
(ANCOVA) revealed that the measured values of FA, MD, and RD differed significantly (p < 
0.001) between the sub-regions when controlling for age (Table 2). Tukey's tests were 
performed for pairwise comparisons between the sub-regions for significantly differing values 
of the measured parameters (Figures 3 i-l). Estimates of the effect size of region on the 
distribution of FA, MD, RD, and AxD are shown in Table 2. Partial omega-squared (ω2), being 




Figure 3: Scatter plots of DTI parameters versus age with linear regression lines: (a) fractional 
anisotropy, (b) mean diffusivity, (c) radial diffusivity, and (d) axial diffusivity in the whole 
corpus callosum. Figures (e)-(h) are the same type of scatter plots but stratified by corpus 
callosum sub-region. The significance of age as a contributing factor to the observed trends, 
and the r-squared values, have been given in the Supplementary Tables S2 and S3. Figures (i)-
(l) show the results of Tukey’s multiple comparison tests between regions, with colours 
indicating corresponding significance levels. Values of MD, RD, and AxD are in 10-3 mm2/s.  
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When the effect or the sample size is small, ω2 may carry negative values resulting from the 
bias correction (Okada, 2016). 
 
A post-mortem study (Aboitiz et al., 1992) has shown that when parsing the corpus callosum 
cross-sectionally, the anterior region has the highest density of thin fibres. This starts 
decreasing towards the posterior regions and reaches a minimum before increasing again 
towards the posterior end. An opposite trend is observed for the density of fibres with a larger 
diameter. This density distribution of axonal diameter has been visualised in Figure 4a, in an 
ROI that provides a cross-sectional view of the corpus callosum. Another study (Barazany et 
al., 2009) has reported a positive correlation between RD and axon diameter in the corpus 
callosum of rat brain, potentially due to larger diameters leading to lower packing density and 
a subsequent increase in perpendicular diffusion. This relationship has been found to hold 
true in our study in the human corpus callosum as visualised in Figure 4b, even though we 
followed a different scheme of sub-division. The regional variations observed in DTI 
parameters in the cross-sectional corpus callosum ROI (Table 2) could likely be due to the 
varying density of axons with larger and smaller diameters that connect different regions of 
the two brain hemispheres (Figure 4a). An interesting finding here was that regional variations 
did not affect AxD values of the corpus callosum; this may be due to the relatively simpler and 
unidirectional nature of axons in the regions analysed. Our analysis suggests that variations 
in DTI properties between sub-regions in the corpus callosum are significant. Therefore, 
studies investigating the diffusion properties of corpus callosum in ageing or disease may be 
better served by analysing each sub-region separately. This has scope to reduce the variance 
observed in measured data, since our analysis indicates that at least 25% of variance can be 
explained by region-wise differences in the case of the parameters FA, MD, and RD (Table 2). 
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Table 2: Results of ANCOVA between regions 1 – 5 in HC, testing for the effects of regional 
differences after controlling for the effects of age.  
Parameter Cumulative p-value (ANCOVA) ω2 
FA < 0.001 0.295 
MD < 0.001 0.291 
RD < 0.001 0.330 
AxD 0.006 0.019 
 
 
Figure 4: (a) Density distribution of small and large diameter axons in the corpus callosum; 
picture adapted with permission (Aboitiz et al., 1992). (b) Distribution of FA and RD values in 
the corpus callosum sub-regions were observed to follow a similar trajectory. Although the 
sub-division scheme used in this study is different to that used in (a), it can be observed that 
the minimum and maximum density for smaller and larger diameter fibres occur in region B3 
(isthmus) which is approximately the same as region 4 in the Hofer scheme; where the 
minimum and maximum for FA and RD distributions have respectively been observed. 
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3.4 Comparison between MCI and healthy ageing: data indicating motor-related 
impairment in MCI reveal merits of corpus callosum analysis by sub-region 
The effects of MCI on the corpus callosum and its sub-regions were investigated using data 
from cohorts HC and MCI (Figure 5). Initial tests were carried out on the whole corpus 
callosum ROI using ANCOVA (Figure 5a); they revealed subtle but significant differences 
between HC and MCI groups in FA, RD, and AxD, after controlling for the effects of age 
(Supplementary Table S4). Opposing changes in the magnitudes of RD and AxD (decrease and 
increase respectively), for patients with MCI compared to HC, may have masked any changes 
in MD (Supplementary Material Figure S3).  
 
It is worth noting that the measured values for FA in MCI were higher than those for HC, and 
that the values for MD and RD were lower in MCI than for HC. This contradicts previous 
reports which showed trends of lower FA and higher diffusivities in degeneration (Amlien et 
al., 2013; Liu et al., 2013; Nowrangi et al., 2013; Wang et al., 2013), but seems to suggest a 
role for inflammation in MCI as indicated by increasing FA and decreasing diffusivities (Gupta 
et al., 2008; Nath et al., 2007; Renoux et al., 2006). This reportedly suggests either intracellular 
inflammation with inflow of extracellular water in the axons or decreased extracellular space 
due to cellular infiltration by inflammatory cells (Renoux et al., 2006). Neuroinflammation in 
MCI and Alzheimer's disease has not been extensively studied in this context. Advanced 
diffusion models of the brain such as those quantifying extracellular free-water volume are 
emerging markers being used to study neuro-inflammation (Pasternak et al., 2016, 2012), but 




Figure 5: (a) Linear trends of FA, MD, RD and AxD, for HC and MCI groups, in the whole corpus 
callosum, with corresponding density plots (smoothed histograms) (b)  Density plots of FA, 
MD, RD and AxD visualised separately in the corpus callosum sub-regions. Values of ω2 and 
their p-values for differences in measurements between HC and MCI are shown on the plots 
where they were observed to be statistically significant. * denotes p < 0.05 and ** denotes p 
< 0.01. ω2 and their p-values for the remaining figures have been given in Supplementary 
Tables S4 and S5. Values of MD, RD, and AxD are in 10-3 mm2/s. 
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Investigation of region-specific measurements provided a better insight into differences 
between HC and MCI subjects (Figure 5b). Supplementary Table S5 summarises the results of 
analysis using ANCOVA, controlling for the effects of age. Values of MD, RD, and AxD differed 
significantly (p < 0.05) between HC and MCI in region 2, and that of AxD differed significantly 
(p < 0.05) in region 3. This indicates that degenerative changes observed in MCI are dominant 
in regions 2 and 3 of the corpus callosum; and that they may be more extensive in region 2 
than in region 3. It must be noted that although the effect sizes of MCI in regions 2 and 3 for 
the significantly different DTI parameters (Supplementary Table S5) were higher than in other 
regions, their values were still small. This might be accounted for by subtle differences 
between HC and MCI during the early stages of cognitive impairment.  
 
Physiological interpretations for RD have included demyelination, and that for AxD have 
included axonal degeneration (Song et al., 2002, 2003). They suggest that the corpus callosum 
integrity is likely to be diminished in MCI, potentially playing a role in progression to 
Alzheimer's disease. In a prior study with data from ADNI-2 participants, DTI properties in 
several white matter structures were compared for patients with MCI, Alzheimer’s disease 
patients, and healthy controls (Nir et al., 2013). They found widespread anisotropy and 
diffusivity alterations in elderly patients with Alzheimer’s disease. They also reported that 
diffusivity measures were more sensitive to microstructural alterations than FA and could 
detect subtle differences in patients with MCI compared to controls. This was supported by 
the results from the analysis of corpus callosum sub-regions in the present study that revealed 




Region 2 of the corpus callosum projects to pre-motor and supplementary motor areas, and 
region 3 to primary motor areas of the brain (Hofer and Frahm, 2006). An effect of MCI, 
indicated by significantly different diffusivity measurements in regions 2 and 3 as reported in 
this study, may help explain motor impairments seen in MCI and pre-clinical Alzheimer’s 
disease (Buchman and Bennett, 2011; de Paula et al., 2016; Förstl and Kurz, 1999; Wirths and 
Bayer, 2008). Neurophysiological examination data, accompanying individual ADNI-3 
participant scans, was used to test this hypothesis. These data were collected as part of the 
screening process and provide preliminary information about a range of functional networks 
including motor, visual and auditory systems. They are summarised in Table 3 and show that 
a higher proportion of MCI subjects than HC were reported to show tremors, abnormal 
reflexes and impaired gait. It is interesting to note that this pattern was observed only in 
motor-related functions, and not in the results of visual or auditory examinations. This 
suggests that an impairment in motor skills is observed for MCI, supporting our results that 
indicate alterations in the corpus callosum regions projecting to motor areas of the brain. 
 
The results of our study agree with data from previous studies (Snir et al., 2019; de Laat et al., 
2011; Bhadelia et al., 2009) that show significant correlations between altered FA in the genu 
of the corpus callosum and abnormal gait function. It must be noted that our study found an 
increase in FA in these regions of interest whereas these studies report a decrease in FA. Due 
to the non-specific nature of DTI, it is difficult to establish the exact nature of pathological 
changes that may be occurring in the corpus callosum in MCI. A decrease in diffusivity values 
in regions 2 and 3 of the corpus callosum may indicate demyelination or axonal degeneration 
(Song et al., 2002, 2003), in the commissural tracts in the anterior parts of the corpus 
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callosum, resulting in diminished processing of information in the pre-motor, supplementary 
motor and primary motor areas of the brain. 
 
Table 3: Summary of neurophysiological examinations of ADNI subjects, showing the 
percentage of subjects with abnormal results. The data shows an increase in motor-related 





Visual impairment 5.6 3.6 
Auditory impairment 6.5 7.1 
Presence of tremors 8.4 21.4 
Abnormal tendon reflexes 7.5 10.7 
Abnormal plantar reflexes 0.9 3.6 
Abnormal gait 8.4 21.4 
 
4. Conclusions 
Analysis of FA, MD, RD and AxD revealed that the properties of the corpus callosum are better 
characterised when segmented as five sub-regions, as opposed to as a single structure. Using 
this approach revealed changes in corpus callosum regions 2 and 3 of MCI subjects compared 
to HC, changes which were undetectable using the single ROI approach. The significance of 
the MCI-associated change is that regions 2 and 3 project to pre-motor, supplementary motor 
and motor areas of the brain. The DTI alterations in these regions were supported with 
evidence from ADNI-documented neurophysiological exams of these subjects, confirming 
that patients with MCI were more likely than HC to experience motor-related deficits, 
24 
 
compared to other impairments.  A limitation to the interpretation of the neuroscience 
findings, enabled by the method adopted for this study, is the lack of detailed information 
about motor functions in the ADNI neurophysiological exams conducted as part of screening. 
The ADNI evaluations only indicate the presence or absence of abnormalities. Availability of 
detailed test results in the future may help estimate the correlation between DTI parameters, 
tremors, reflexes and gait, providing insight into the extent of the role of corpus callosum in 
motor impairment as observed in MCI and potentially, pre-clinical Alzheimer’s disease.  
 
In summary, we anticipate that the method demonstrated in this study will advance the 
detection in a clinical setting of alterations to the structure of the corpus callosum, and 
corresponding impacts on brain function, using this comparatively simple method to obtain 
the ROIs and supporting statistical analysis. 
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Figure S1: Results of a longitudinal analysis of DTI images of age-matched 14 HC and 14 MCI 
subjects between 65 and 75 years old from ADNI-2, acquired with the same set of scan 
parameters. The plots show the trajectories of average FA, MD, RD, and AxD values for each 
cohort over a time period of 1 year. ‘b’ denotes baseline, ‘3’, ‘6’, and ‘12’ denote a 3-month, 
6-month, and 12-month follow-up after the baseline visit. Although the longitudinal analysis 
gives a valuable insight into differences between HC and MCI cohorts, this is limited to a 1-
year time span. Moreover, the results indicate a pattern of change with respect to the 




Figure S2: Multiple regression plots of (a) fractional anisotropy (FA), (b) mean diffusivity (MD), 
(c) radial diffusivity (RD), and (d) axial diffusivity (AxD) in the corpus callosum of subjects from 
cohort HCsub. The contribution of each factor, i.e., age, gender and their interaction, to the 
observed linear relationship is tested using the null hypothesis about its correlation with the 
DTI parameters; an output p-value is obtained based on testing the null hypothesis that the 
factor has no effect. The factor is considered significant if ‘p’ is less than 0.05. p(age:gender) 






Figure S3: Plots showing the relationships between MD, RD and AxD of HC and MCI subjects. 
Equations using diffusion tensor eigen values, RD = (λ2 + λ3)/2, AxD = λ1 and MD = (λ1 + λ2 + 
λ3)/3, imply a linear relationship between MD and RD + AxD. These equations are used to 
generate plots that show a decrease in RD and an increase in AxD in MCI individuals compared 
to HC, for a given value of MD. The plot on the right suggests that these opposing patterns 
(represented by RD + AxD) bring the MD values of HC and MCI subjects closer to each other, 







Table S1: Linear regression equations modelling ageing in the corpus callosum of subjects in 
HCsub, stratified by gender. 
DTI parameter Males Females 
Fractional anisotropy 0.75 – 0.0012 * age 0.77 – 0.0015 * age 
Mean diffusivity 0.54 + 0.0045 * age 0.59 + 0.0036 * age 
Radial diffusivity 0.22 + 0.0035 * age 0.23 + 0.0032 * age 
Axial diffusivity 1.3 + 0.006 * age 1.34 + 0.005 * age 
 
 
Table S2: Linear regression equations modelling ageing in the whole corpus callosum ROI of 
subjects in cohort HC. 
DTI parameter Equation r2 p-value  
Fractional anisotropy 0.79 – 0.0018 * age 0.11  < 0.001 
Mean diffusivity 0.53 + 0.0045 * age 0.34 < 0.001 
Radial diffusivity 0.18 + 0.004 * age 0.23 < 0.001 





Table S3: Linear regression equations modelling ageing in the corpus callosum sub-regions of 
subjects in cohort HC. 
DTI parameter Region 1 r2 p-value  
FA 0.9 – 0.0026* age 0.12  < 0.001 
MD 0.44 + 0.0052 * age 0.29 < 0.001 
RD 0.01 + 0.0054 * age 0.23 0.84 
AxD 1.29 + 0.0055 * age 0.19 < 0.001 
DTI parameter Region 2 r2 p-value  
FA 0.78 – 0.0017 * age 0.028  < 0.001 
MD 0.39 + 0.0065 * age 0.27 < 0.001 
RD 0.07 + 0.0056 * age 0.16 0.42 
AxD 1.08 + 0.0079 * age 0.17 < 0.001 
DTI parameter Region 3 r2 p-value  
FA 0.78 – 0.0015 * age 0.012  < 0.001 
MD 0.54 + 0.0044 * age 0.102 < 0.001 
RD 0.22 + 0.0034 * age 0.04 < 0.05 
AxD 1.19 + 0.0067 * age 0.07 < 0.001 
DTI parameter Region 4 r2 p-value  
FA 0.84 – 0.003 * age 0.04  < 0.001 
MD 0.49 + 0.0062 * age 0.15 < 0.001 
RD 0.1 + 0.0065 * age 0.1 0.5 
AxD 1.27 + 0.0064 * age 0.07 < 0.001 
DTI parameter Region 5 r2 p-value  
FA 0.86 – 0.0015 * age 0.05  < 0.001 
MD 0.56 + 0.003 * age 0.19 < 0.001 
RD 0.15 + 0.0027 * age 0.115 < 0.01 






Table S4: Linear regression equations modelling ageing in the whole corpus callosum ROI of 
subjects in cohort MCI (corresponding equations for cohort HC given in Table S2). Here r2 
denotes the proportion of variance in the DTI parameters explained by age through linear 
regression modelling (data includes subjects from both HC and MCI cohorts). ω2 denotes the 
effect size of disease (MCI) in the DTI parameter, with a significance level denoted by the 
corresponding p-value. 
 
Parameter MCI equation r2 ω2 p-value  
FA 0.77 – 0.001 * age 0.02 0.13  < 0.001 
MD 0.67 + 0.0025 * age 0.13 -0.006 0.68 
RD 0.26 + 0.0022 * age 0.08 0.05 < 0.01 




Table S5: Linear regression equations modelling ageing in the whole corpus callosum ROI of 
subjects in cohort MCI. r2 denotes the proportion of variance in the DTI parameter explained 
by age through linear regression modelling. ω2 denotes the effect size of disease (MCI) in the 
DTI parameter, with a significance level denoted by the corresponding p-value. 
Parameter Region 1 MCI equation r2 ω2 p-value  
FA 0.82 – 0.0013 * age 0.035 -0.007  0.89 
MD 0.62 + 0.003 * age 0.12 0.004 0.21 
RD 0.21 + 0.002 * age 0.11 -0.001 0.35 
AxD 1.55 + 0.002 * age 0.002 0.003 0.24 
Parameter Region 2 MCI equation r2 ω2 p-value  
FA 0.817 – 0.002 * age 0.04 -0.006 0.7 
MD 0.55 + 0.005 * age 0.076 0.063 < 0.005 
RD 0.109 + 0.005 * age 0.082 0.024 < 0.05 
AxD 1.52 + 0.003 * age 0 0.062 < 0.005 
Parameter Region 3 MCI equation r2 ω2 p-value  
FA 0.8 – 0.0015 * age 0 -0.004 0.47 
MD 0.77 + 0.002 * age 0 0.012 0.11 
RD 0.33 + 0.002 * age 0 -0.006 0.65 
AxD 1.78 - 0.0001 * age 0 0.025 < 0.05 
Parameter Region 4 MCI equation r2 ω2 p-value  
FA 0.75 – 0.0015 * age 0 0.008 0.15 
MD 0.78 + 0.002 * age 0 -0.007 0.92 
RD 0.39 + 0.002 * age 0 -0.004 0.51 
AxD 1.68 + 0.0014 * age 0 0.008 0.15 
Parameter Region 5 MCI equation r2 ω2 p-value  
FA 0.78 – 0.0004 * age 0 -0.007 0.86 
MD 0.72 + 0.001 * age 0.007 0.001 0.29 
RD 0.31 + 0.0008 * age 0 0.006 0.18 
AxD 1.56 + 0.0017 * age 0 -0.005 0.6 
 
 
